Karyopharm Therapeutics (KPTI) Property, Plant & Equipment (Net) (2012 - 2026)
Karyopharm Therapeutics (KPTI) reported Property, Plant & Equipment (Net) of $94,000 for Q2 2026, down 61.5% from $244,000 a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Property, Plant & Equipment (Net) (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics posted Property, Plant & Equipment (Net) of $104,000, down 74.0% from FY2024.
- Property, Plant & Equipment (Net) has declined for seven consecutive years, with a five-year compound annual growth rate of -45.8% (FY2020 to FY2025).
- By year, Property, Plant & Equipment (Net) came in at $400,000 in FY2024 (-34.0%), $606,000 in FY2023 (-46.8%), $1.14 million in FY2022 (-30.6%) and $1.64 million in FY2021 (-26.0%).
- The Q2 2026 figure ranks as the lowest quarterly Property, Plant & Equipment (Net) in data going back to Q4 2012.
- Over the past five years, the year-over-year decline in Property, Plant & Equipment (Net) ranged from 15.3% (Q1 2024) to 75.4% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 29.29 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 5.80 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 25.74 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 10.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 13.62 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 8.55 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 5.83 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 19.03 Bn |
| 10 | Karyopharm Therapeutics | 15.05 Mn | -211.38 Mn | 32.35 Mn | 94,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 495,000.00 |
| Jun 30, 2024 | 628,000.00 |
| Mar 31, 2024 | 719,000.00 |
| Dec 31, 2023 | 606,000.00 |
| Sep 30, 2023 | 686,000.00 |
| Jun 30, 2023 | 766,000.00 |
| Mar 31, 2023 | 849,000.00 |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.54 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 1.76 Mn |
API Access
Karyopharm Therapeutics Property, Plant & Equipment (Net) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "property-plant-and-equipment-net", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();